Even America’s Heroes Get Melanoma
…the Basics I was diagnosed in 2010 with melanoma on my right shin, close to my calf. I was only…
Even America’s Heroes Get Melanoma
…the Basics I was diagnosed in 2010 with melanoma on my right shin, close to my calf. I was only…
,
Why Fresh-Frozen Primary Tissue is Critically Important in the Fight Against Melanoma
…article seeks to help melanoma patients, survivors, caregivers, and family members understand why fresh-frozen primary tissue is so critically important…
,
Survivor Spotlight: Acral Melanoma Survivor
…results showed that Lisa had an early in situ nail matrix melanoma. At this point, Lisa contacted AIM at Melanoma,…
,
Parenting While Living With Melanoma
…to avoid burdening them. “It’s an almost universal concern,” Fehon said. But withholding information about a melanoma diagnosis or what…
,
,
Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
…One-Time Cell Therapy for Patients with Advanced Melanoma SAN CARLOS, Calif., May 26, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc.…
,
,
Receiving a Heart Increases Melanoma Risk
…to a recent analysis, this risk extends specifically to melanoma. Data pooled from multiple independent studies shows heart transplant recipients…
Managing Melanoma During the Holiday Season
Navigating Melanoma During the Holidays The holiday season is often a time of joy, celebration, and connection. But for individuals…
,
What Inspires Leading Melanoma Researchers?
…Melanoma Research and Patients These powerful words shared by researchers during the event reflect the passion and dedication that continue…
,
Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
…called unresectable or metastatic melanoma. Amtagvi is used when your melanoma has not responded or stopped responding to a PD-1…
,
,
Webinar: Post-ASCO Melanoma Research Update
…Margaret Cancer Centre in Toronto. Dr. Sondak is internationally recognized for his leadership in melanoma surgery, staging, and treatment advances,…
,
Recent Posts
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026
Promising early results with imneskibart, low-dose subcutaneous IL-2, and nivolumab in patients who do not respond to or who relapse after receiving combination checkpoint inhibitors
Jun. 05, 2026